文献速递消化道肿瘤与早癌食管胃疾病与幽门螺杆菌

胃癌症的多因素病因、进展及治疗弱点的整合蛋白质基因组学图谱

Integrative proteogenomics maps multifactorial aetiology, progression and therapeutic vulnerabilities in gastric cancer.
PubMed 文献 · Gut · 2026-04-07

该研究对154例未经治疗的台湾患者配对肿瘤、癌旁黏膜和血液进行多组学整合分析,结合外显子组、转录组、蛋白质组、磷酸化蛋白质组、致癌物特征、HP状态、微生物组和解剖定位。研究发现多环芳烃特征(二苯并[a,h]吖啶)为高风险暴露,定义三种起始生态及微生物相关亚型,决策树模型可改进复发和生存预测。

要点

  • 多环芳烃暴露特征与胃癌侵袭、免疫抑制和不良生存相关。
  • 整合多组学定义三种起始生态及微生物相关亚型。
  • 暴露与蛋白质组免疫状态联合模型可改进预后预测。

核心结论

  • 该蛋白质基因组学框架定义了暴露相关和微生物相关的胃癌亚型,为患者分层、预防和可操作治疗弱点提供分子图式。

研究设计与样本

  • 研究建立154例未经治疗的台湾患者配对肿瘤、癌旁黏膜和血液的多组学图谱,整合全外显子测序、RNA-seq、蛋白质组和磷酸化蛋白质组与致癌物特征、HP状态、微生物组成及精细解剖定位。
  • 采用基于细胞的功能试验测试致癌物效应,并在独立队列中评估微生物亚型。

主要发现

  • 多环芳烃特征二苯并[a,h]吖啶为高风险暴露,促进侵袭、免疫抑制和不良生存,在该队列中显著超过亚硝胺相关风险。
  • 多层整合定义三种起始生态:HP驱动的炎症性、非HP微生物富集的免疫沉默性和无HP微生物耗竭状态。
  • 在HP阴性肿瘤中,链球菌富集亚型与紧密连接(CLDN18.2/ZO-1/OCLN)破坏和上皮间质转化相关,而部分临床侵袭性病例保留CLDN18.2高表达上皮稳定亚型以供治疗可及。
  • 独立队列显示胃液来源的咽峡炎链球菌丰度与紧密连接蛋白呈负相关。
  • 解剖定位揭示位置特异性、性别特异性、亚型特异性致癌网络和激酶活性,包括临床生物标志物阴性肿瘤中的CDK4激活。

临床怎么用

  • 可利用暴露和微生物相关亚型对胃癌患者进行分子分层。
  • CLDN18.2高表达上皮稳定亚型可能为临床侵袭性病例提供治疗可及性。
  • 结合暴露和蛋白质组免疫状态的决策树模型可辅助预测复发和生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer, with disproportionately higher incidence in East Asia, arises from complex host-microbiome-environment interactions beyond Helicobacter pylori (HP) infection. However, the molecular architecture linking environmental carcinogens, microbial succession and host response remains unclear. OBJECTIVE: To delineate multifactorial aetiologies and clinically actionable subtypes/biomarkers of gastric cancer through integrative proteogenomic, microbial and environmental exposure profiling. DESIGN: We established a multiomics atlas of paired tumour, adjacent mucosa tissues and blood from 154 treatment-naïve Taiwanese patients, integrating whole-exome sequencing, RNA-seq, proteome and phosphoproteome profiling with carcinogen signatures, HP status, microbiome composition and refined anatomical mapping. Cell-based functional assays tested carcinogen effects. Microbial subtype was assessed in an independent cohort. RESULTS: A polycyclic-aromatic-hydrocarbon signature, dibenz[a,h]acridine, emerged as a high-risk exposure promoting invasion, immune suppression and poor survival, significantly exceeding nitrosamine-linked risk in this cohort. Multilayer integration defined three initiation ecologies: HP-driven inflammatory, non-HP microbiome-enriched immune-silent and HP-free microbially depleted states. Among HP-negative tumours, a Streptococcus-enriched subtype associated with tight-junction (CLDN18.2/ZO-1/OCLN) disruption and epithelial-mesenchymal transition, whereas a subset of clinically aggressive cases retained CLDN18.2-high epithelial-stable subtype for therapeutic accessibility. An independent cohort revealed gastric juice-derived Streptococcus anginosus abundance inversely correlated with tight-junction proteins. Anatomical mapping reveals location-specific, sex-specific, subtype-specific oncogenic networks and kinase activity, including CDK4 activation in clinical biomarker-negative tumours. Decision-tree models combining exposure and proteome-immune states refined recurrence and survival prediction beyond stage. CONCLUSION: This proteogenomic framework defines exposure-informed and microbiome-informed gastric cancer subtypes, providing a molecular schema for patient stratification, prevention and actionable therapeutic vulnerabilities.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Chang YH, Hong TC, Lin KT, et al. Integrative proteogenomics maps multifactorial aetiology, progression and therapeutic vulnerabilities in gastric cancer. Gut. 2026. PMID: 41617485. doi:10.1136/gutjnl-2025-337247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。